Serum response factor is alternatively spliced in human colon cancer

Journal of Surgical Research

Volumn 121, Issue 1, 2004, Pages 92-100

  Patten, Lane C ^a   Belaguli, Narasimhaswamy S ^a   Baek, Moo Jun ^a   Fagan, Shawn P ^a   Awad, Samir S ^a   Berger, David H ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

alternative splicing; colon cancer; epithelial cells; serum response factor

Indexed keywords

ISOPROTEIN; SERUM RESPONSE FACTOR;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HT29; CELL SURVIVAL; COLON ADENOCARCINOMA; COLON MUCOSA; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTESTINE CELL; PRIORITY JOURNAL; WESTERN BLOTTING;

ALTERNATIVE SPLICING; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; HUMANS; RATS; SERUM RESPONSE FACTOR;

EID: 4143132483     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2004.02.031     Document Type: Article

References (32)

1. Treisman R. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell. 46:1986;567
2. Treisman R. Identification and purification of a polypeptide that binds to the c-fos serum response element. EMBO J. 6:1987;2711
3. Belaguli N.S., Shildmeyer L.A., Schwartz R.J. Organization and myogenic restricted expression of the murine serum response factor gene. J. Biol. Chem. 272:1997;18222
4. Treisman R. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′′ element and c-fos 3′′ sequences. Cell. 42:1985;889
5. Greenberg M.E., Siegfried Z., Ziff E.B. Mutation of the c-fos dyad symmetry element inhibits serum inducibility of transcript in vivo and the nuclear regulatory factor binding in vitro. Mol. Cell Biol. 7:1987;1217
6. Treisman R. The serum response element. Trends Biochem. Sci. 17:1992;423
7. Vandromme M., Gauthier-Rouviere C., Carnac G., Lamb N., Fernandez A. Serum response factor, p67 SRF, is expressed and required during myogenic differentiation of both mouse C2 and rat L6 muscle cell lines. J. Cell Biol. 118:1992;1489
8. Croissant J.D., Kim J.H., Eichele G., Goering L., Lough J., Prywes R., Schwartz R.J. Avian serum response factor expression restricted primarily to muscle cell lineage is required for alpha-actin gene transcription. Dev. Biol. 177:1996;250
9. Bertolotto C., Ricci J.E., Luciano F., Mari B., Chambard J.C., Auberger P. Cleavage of the serum response factor during death receptor-induced apoptosis results in an inhibition of the c-fos promoter transcriptional activity. J. Biol. Chem. 275:2000;12941
10. Hill C.S., Wynne J., Treisman R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell. 81:1995;1159
11. Phiel C.J., Gabbeta V., Parsons L.M., Rothblat D., Harvey R.P., McHugh K.M. Differential binding of an SRF/NK-2/MEF2 transcription factor complex in normal versus neoplastic smooth muscle tissue. J. Biol. Chem. 276:2001;34637
12. Pschiari E., Balmain A., Plows D., Zoumpourlis V., Pintzas A. High activity of serum response factor in mesenchymal transition of epithelial tumor cells is regulated by RhoA signaling. J. Biol. Chem. 277:2002;29490
13. Arsenian S., Weinhold B., Oelgeschlager M., Ruther U., Nordheim A. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J. 17:1998;6289
14. Lopez J.A. Developmental role of transcription factor isoforms generated by alternative splicing. Dev. Biol. 172:1995;396
15. Belaguli N.S., Zhou W., Trinh T.H., Majesky M.W., Schwartz R.J. Dominant negative murine serum response factor Alternative splicing within the activation domain inhibits trans-activation of serum response factor binding targets. Mol. Cell. Biol. 19:1999;4582
16. Davis F.J., Gupta M., Pogwizd S.M., Bacha E., Jeevanandam V., Gupta M.P. Increased expression of alternatively spliced dominant-negtive isoform of SRF in human failing hearts. Am. J. Physiol. Heart Circ. Physiol. 282:2002;H1521
17. Yang Y., Beqaj S., Kemp P., Ariel I., Schuger L. Stretch-induced alternative splicing of serum response factor promotes bronchial myogenesis and is defective in lung hypoplasia. J. Clin. Invest. 106:2000;1321
18. Landerholm T.E., Dong X.R., Lu J., Belaguli N.S., Schwartz R.J., Majesky M.W. A role for serum response factor in coronary smooth muscle differentiation from proepicardial cells. Development. 126:1999;2053
19. Kemp P.R., Metcalfe J.C. Four isoforms of serum response factor that increase or inhibit smooth-muscle-specific promoter activity. Biochem. J. 345:2000;445
20. Sheng H., Shao J., Dixon D.A., Williams C.S., Prescott S.M., DuBois R.N., Beauchamp R.D. Transforming growth factor-β1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J. Biol. Chem. 275:2000;6628
21. Fujimoto K., Sheng H., Shao J., Beauchamp R.D. Transforming growth factor-β1 promotes invasiveness after cellular transformation with activated ras in intestinal epithelial cells. Exp. Cell Res. 266:2001;239
22. Treisman R. Journey to the surface of the cell Fos regulation and the SRE. EMBO J. 14:1995;4905
23. Johansen F.E., Prywes R. Serum response factor Transcriptional regulation of genes induced by growth factors and differentiation. Biochim. Biophys. Acta. 1242:1995;1
24. Shore P., Sharrocks A.D. The MADS-box family of transcription factors. Eur. J. Biochem. 229:1995;1
25. Drewett V., Devitt A., Saxton J., Portman N., Greaney P., Cheong N.E., Alnemri T.F., Alnemri E., Shaw P.E. Serum response factor cleavage by caspases 3 and 7 linked to apoptosis in human BJAB cells. J. Biol. Chem. 276:2001;33444
26. Pignatelli M., Luna-Medina R., Perez-Rendon A., Santos A., Perez-Castillo A. The transcription factor early growth response factor-1 (EGR-1) promotes apoptosis of neuroblastoma cells. Biochem. J. 373:2003;739
27. Lynch K.W., Weiss A. A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras. Mol. Cell. Biol. 20:2000;70
28. Weg-Remers S., Ponta H., Herrlich P., Konig H. Antagonistic signaling pathways regulate alternative splicing of CD44 in T cells. Ann. N.Y. Acad. Sci. 973:2002;112
29. Rajesh D., Schell K., Verma A.K. Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase I and 2A. Mol. Pharmacol. 56:1999;515
30. Bergmann-Leitner E.S., Abrams S.I. Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attack. Cancer Immunol. Immunother. 49:2000;193
31. Gayet J., Zhou X.P., Duval A., Rolland S., Hoang J.M., Cottu P., Hamelin R. Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene. 20:2001;5025
32. Ross P.J., George M., Cunningham D., DiStefano F., Andreyev H.J., Workman P., Clarke P.A. Inhibition of Kirsten-ras expression in human colorectal cancer using rationally selected Kirsten-ras antisense oligonucleotides. Mol. Cancer Ther. 1:2001;29